David Hallal has served as the Chairman of our Board of Directors since July 2017. He is a proven 30-year veteran in the biopharmaceutical industry, having grown and operated several successful biotechnology companies. David serves as Chairman and Chief Executive Officer of ElevateBio, and he is also Chairman of AlloVir, an ElevateBio portfolio company. During his 10-year tenure at Alexion Pharmaceuticals, where he served as Chief Executive Officer, Chief Operating Officer and Chief Commercial Officer, he led the pipeline expansion from a single-product to multi-product company, resulting in Alexion’s inclusion into the S&P500. Prior to Alexion, David spent nearly 20 years at Amgen, Biogen, and Eyetech in executive and senior leadership roles.
He also serves as the Chairman of the Board of Directors of iTeos Therapeutics SA and as a member of the Board of Directors of Seer Biosciences, Inc. Mr. Hallal holds a BA in psychology from the University of New Hampshire.
Chairman of the Scholar Rock Board and Chief Executive Officer of ElevateBio